(Q39230016)
Statements
1 reference
Efficacy and safety of recombinant C1 inhibitor for the treatment of hereditary angioedema attacks: a North American open-label study (English)
1 reference
Marc A Riedl
1 reference
Robyn J Levy
1 reference
Daniel Suez
1 reference
Richard F Lockey
1 reference
James W Baker
1 reference
Anurag Relan
1 reference
Bruce L Zuraw
1 reference
6 March 2013
1 reference
1 reference
110
1 reference
4
1 reference
295-299
1 reference
Identifiers
1 reference
1 reference